Simplex Trading, LLC Entera Bio Ltd. Transaction History

Simplex Trading, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 25, 2024	SELL	$1.73 - $2.98 $60 - $104	-35 Reduced 11.86%	260 $0
Q1 2024 Apr 25, 2024	BUY	$0.64 - $1.72 $188 - $507	295 New	295 $0
Q3 2023 Nov 01, 2023	SELL	$0.6 - $0.88 $7 - $11	-13 Reduced 13.13%	86 $0
Q2 2023 Aug 04, 2023	BUY	$0.68 - $1.01 $67 - $99	99 New	99 $0
Q2 2022 Aug 03, 2022	SELL	$1.33 - $2.95 $305 - $678	-230 Closed	0 $0
Q1 2022 May 02, 2022	SELL	$1.91 - $3.23 $1,302 - $2,202	-682 Reduced 74.78%	230 $0
Q4 2021 Feb 23, 2022	SELL	$2.82 - $4.79 $52,251 - $88,753	-18,529 Reduced 95.31%	912 $2,000
Q3 2021 Oct 28, 2021	BUY	$4.43 - $6.29 $16,386 - $23,266	3,699 Added 23.5%	19,441 $122,000
Q2 2021 Aug 12, 2021	BUY	$2.92 - $6.5 $45,966 - $102,323	15,742 New	15,742 $94,000

5.34M

2.6K

100

Ticker ENTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,809,900
Market Cap $49.8M
Description
Entera Bio Ltd., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of orally delivered large molecule therapeutics for unmet medical needs. The company's lead product candidates include the EB612, which is in Phase II clinical trials for the treatment of hypoparathyroidism; and EB613 that has completed ...

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Simplex Trading, LLC with notifications on news.